280 related articles for article (PubMed ID: 24231349)
1. Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
Wang H; Heijnen CJ; van Velthoven CT; Willemen HL; Ishikawa Y; Zhang X; Sood AK; Vroon A; Eijkelkamp N; Kavelaars A
J Clin Invest; 2013 Dec; 123(12):5023-34. PubMed ID: 24231349
[TBL] [Abstract][Full Text] [Related]
2. Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.
Singhmar P; Huo X; Eijkelkamp N; Berciano SR; Baameur F; Mei FC; Zhu Y; Cheng X; Hawke D; Mayor F; Murga C; Heijnen CJ; Kavelaars A
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3036-41. PubMed ID: 26929333
[TBL] [Abstract][Full Text] [Related]
3. Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK.
Eijkelkamp N; Wang H; Garza-Carbajal A; Willemen HL; Zwartkruis FJ; Wood JN; Dantzer R; Kelley KW; Heijnen CJ; Kavelaars A
J Neurosci; 2010 Sep; 30(38):12806-15. PubMed ID: 20861385
[TBL] [Abstract][Full Text] [Related]
4. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors.
Joseph EK; Levine JD
Neuroscience; 2010 Aug; 169(1):431-5. PubMed ID: 20457222
[TBL] [Abstract][Full Text] [Related]
5. Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain.
Ferrari LF; Bogen O; Alessandri-Haber N; Levine E; Gear RW; Levine JD
Neuroscience; 2012 Oct; 222():392-403. PubMed ID: 22796071
[TBL] [Abstract][Full Text] [Related]
6. GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain.
Eijkelkamp N; Heijnen CJ; Willemen HL; Deumens R; Joosten EA; Kleibeuker W; den Hartog IJ; van Velthoven CT; Nijboer C; Nassar MA; Dorn GW; Wood JN; Kavelaars A
J Neurosci; 2010 Feb; 30(6):2138-49. PubMed ID: 20147541
[TBL] [Abstract][Full Text] [Related]
7. Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.
Wang HJ; Gu HX; Eijkelkamp N; Heijnen CJ; Kavelaars A
Front Pharmacol; 2018; 9():592. PubMed ID: 29922165
[No Abstract] [Full Text] [Related]
8. GRK2 in sensory neurons regulates epinephrine-induced signalling and duration of mechanical hyperalgesia.
Wang H; Heijnen CJ; Eijkelkamp N; Carbajal AG; Schedlowski M; Kelley KW; Dantzer R; Kavelaars A
Pain; 2011 Jul; 152(7):1649-1658. PubMed ID: 21514055
[TBL] [Abstract][Full Text] [Related]
9. The role of G-protein-coupled receptor kinase 2 in diabetic mechanical hyperalgesia in rats.
Xu XH; Du RQ; Li L; Yang LL; Zhang Y; Li QM
Eur J Pain; 2021 Oct; 25(9):2039-2049. PubMed ID: 34101933
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124 as a novel treatment for persistent hyperalgesia.
Willemen HL; Huo XJ; Mao-Ying QL; Zijlstra J; Heijnen CJ; Kavelaars A
J Neuroinflammation; 2012 Jun; 9():143. PubMed ID: 22731384
[TBL] [Abstract][Full Text] [Related]
11. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.
Willemen HLDM; Eijkelkamp N; Wang H; Dantzer R; Dorn GW; Kelley KW; Heijnen CJ; Kavelaars A
Pain; 2010 Sep; 150(3):550-560. PubMed ID: 20609517
[TBL] [Abstract][Full Text] [Related]
12. Monocytes/Macrophages control resolution of transient inflammatory pain.
Willemen HL; Eijkelkamp N; Garza Carbajal A; Wang H; Mack M; Zijlstra J; Heijnen CJ; Kavelaars A
J Pain; 2014 May; 15(5):496-506. PubMed ID: 24793056
[TBL] [Abstract][Full Text] [Related]
13. Microglial GRK2: a novel regulator of transition from acute to chronic pain.
Kavelaars A; Eijkelkamp N; Willemen HL; Wang H; Carbajal AG; Heijnen CJ
Brain Behav Immun; 2011 Aug; 25(6):1055-60. PubMed ID: 21473908
[TBL] [Abstract][Full Text] [Related]
14. Acquired Exchange Protein Directly Activated by Cyclic Adenosine Monophosphate Activity Induced by p38 Mitogen-activated Protein Kinase in Primary Afferent Neurons Contributes to Sustaining Postincisional Nociception.
Matsuda M; Oh-Hashi K; Yokota I; Sawa T; Amaya F
Anesthesiology; 2017 Jan; 126(1):150-162. PubMed ID: 27984207
[TBL] [Abstract][Full Text] [Related]
15. Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming.
Ferrari LF; Araldi D; Levine JD
J Neurosci; 2015 Apr; 35(15):6107-16. PubMed ID: 25878283
[TBL] [Abstract][Full Text] [Related]
16. The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain.
Moy JK; Khoutorsky A; Asiedu MN; Black BJ; Kuhn JL; Barragán-Iglesias P; Megat S; Burton MD; Burgos-Vega CC; Melemedjian OK; Boitano S; Vagner J; Gkogkas CG; Pancrazio JJ; Mogil JS; Dussor G; Sonenberg N; Price TJ
J Neurosci; 2017 Aug; 37(31):7481-7499. PubMed ID: 28674170
[TBL] [Abstract][Full Text] [Related]
17. Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways.
Parada CA; Reichling DB; Levine JD
Pain; 2005 Jan; 113(1-2):185-90. PubMed ID: 15621379
[TBL] [Abstract][Full Text] [Related]
18. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors.
St-Jacques B; Ma W
Exp Neurol; 2014 Nov; 261():354-66. PubMed ID: 24910202
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia.
Goode DJ; Molliver DC
J Neurosci; 2021 Mar; 41(13):2883-2898. PubMed ID: 33593853
[TBL] [Abstract][Full Text] [Related]
20. Opioid-Induced Hyperalgesic Priming in Single Nociceptors.
Khomula EV; Araldi D; Bonet IJM; Levine JD
J Neurosci; 2021 Jan; 41(1):31-46. PubMed ID: 33203743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
